Molecular model of an interaction between factor Xa and DX-9065a, a novel factor Xa inhibitor: contribution of the acetimidoylpyrrolidine moiety of the inhibitor to potency and selectivity for serine proteases

Author： Katakura S.   Nagahara T.   Hara T.   Kunitada S.   Iwamoto M.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.30, Iss.5, 1995-01, pp. : 387-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

By Apostolakis Stavros   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1057-1064

Informa Healthcare

Access to resources Recommend Favorite

Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats

By Sato K.   Taniuchi Y.   Kawasaki T.   Hirayama F.   Koshio H.   Matsumoto Y.  

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

By Heran C.   Morgan S.   Kasiewski C.   Bostwick J.   Bentley R.   Klein S.   Chu V.   Brown K.   Colussi D.   Czekaj M.   Perrone M.   Leadley R.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite

Edoxaban: A New Oral Direct Factor Xa Inhibitor

By Camm A. John  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1503-1526

Adis International

Access to resources Recommend Favorite

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy

By Turpie Alexander GG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1373-1384

Informa Healthcare

Access to resources Recommend Favorite